BioVentrix, Inc. (BVXX)

BioVentrix Balance Sheet

Financials in millions usd. Fiscal year is January - December.

Year Ending	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	1.84	2.64
Cash & Cash Equivalents	1.84	2.64
Cash Growth	-30.31%	-
Other Current Assets	0.25	0.1
Total Current Assets	2.09	2.74
Property, Plant & Equipment	0.1	0.15
Goodwill and Intangibles	0.23	0.34
Other Long-Term Assets	0.15	0.05
Total Long-Term Assets	0.48	0.54
Total Assets	2.57	3.28
Accounts Payable	2.09	2.47
Current Debt	8.81	4.48
Other Current Liabilities	2.78	0.78
Total Current Liabilities	13.68	7.73
Long-Term Debt	0.1	0.22
Other Long-Term Liabilities	1.35	0.36
Total Long-Term Liabilities	1.45	0.59
Total Liabilities	15.13	8.32
Total Debt	8.92	4.7
Debt Growth	89.76%	-
Retained Earnings	-231.24	-223.57
Shareholders' Equity	-11.97	-5.04
Net Cash (Debt)	-7.08	-2.06
Working Capital	-11.59	-4.99

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).